Evaluation of Pharmacological Interventions Targeting Pathophysiological Cascades (Oxidative stress, PARP, ER stress, Inflammation, apoptosis) Involved in Stroke (Cerebral Ischemia), Diabetes, Diabetic Complications (neuropathy, encephalopathy & cardiomyopathy), Cognitive impairment (associated with Parkinson’s disease/Stroke) and Neuropathic Pain.

Elucidation of Pharmacological Potential of NCEs in Disease Models for Efficacy Studies

Safety Pharmacological Studies (Core, Follow up and Supplemental SPS) of NCEs